Epilepsy after head injury

Raimondo D'Ambrosio, Emilio Perucca

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

Purpose of review: The purpose of this short review is to provide an update on the epidemiology of posttraumatic epilepsy, associated risk factors, data from prevention studies, and recent breakthroughs in experimental research. Recent findings: There is increasing evidence that neuroimaging findings, stratification by neurosurgical procedures performed, and genomic information (e.g. apolipoprotein E and haptoglobin genotypes) may provide useful predictors of the individual risk of developing posttraumatic epilepsy. While antiepileptic drug prophylaxis can be effective in protecting against acute (provoked) seizures occurring within 7 days after injury, no antiepileptic drug treatment has been found to protect against the development of posttraumatic epilepsy and therefore long-term anticonvulsant prophylaxis is not recommended. Glucocorticoid administration early after head injury also has not been found to reduce the risk of posttraumatic epilepsy. At the basic research level, there have been advances in the understanding of pathophysiological changes in posttraumatic excitatory and inhibitory synapses, and the critical period for epileptogenesis after head injury has been better defined. Finally, the development of a novel animal model, which mimicks more closely human posttraumatic epilepsy, may facilitate efforts to characterize relevant epileptogenic mechanisms and to identify clinically effective antiepileptogenic treatments. Summary: Despite the continuing lack of clinically effective agents for posttraumatic epilepsy prophylaxis, recent advances in basic and clinical research offer new hope for success in the development of new strategies for prevention and treatment.

Original languageEnglish
Pages (from-to)731-735
Number of pages5
JournalCurrent Opinion in Neurology
Volume17
Issue number6
DOIs
Publication statusPublished - Dec 2004

Fingerprint

Craniocerebral Trauma
Epilepsy
Anticonvulsants
Research
Neurosurgical Procedures
Haptoglobins
Apolipoproteins E
Neuroimaging
Synapses
Glucocorticoids
Epidemiology
Seizures
Animal Models
Genotype
Wounds and Injuries

Keywords

  • Antiepileptic drugs
  • Epileptogenesis
  • Head trauma
  • Microdialysis
  • Partial seizures
  • Posttraumatic epilepsy

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Epilepsy after head injury. / D'Ambrosio, Raimondo; Perucca, Emilio.

In: Current Opinion in Neurology, Vol. 17, No. 6, 12.2004, p. 731-735.

Research output: Contribution to journalArticle

D'Ambrosio, Raimondo ; Perucca, Emilio. / Epilepsy after head injury. In: Current Opinion in Neurology. 2004 ; Vol. 17, No. 6. pp. 731-735.
@article{66dddf6ec7d44a349f6d8534f1dd1322,
title = "Epilepsy after head injury",
abstract = "Purpose of review: The purpose of this short review is to provide an update on the epidemiology of posttraumatic epilepsy, associated risk factors, data from prevention studies, and recent breakthroughs in experimental research. Recent findings: There is increasing evidence that neuroimaging findings, stratification by neurosurgical procedures performed, and genomic information (e.g. apolipoprotein E and haptoglobin genotypes) may provide useful predictors of the individual risk of developing posttraumatic epilepsy. While antiepileptic drug prophylaxis can be effective in protecting against acute (provoked) seizures occurring within 7 days after injury, no antiepileptic drug treatment has been found to protect against the development of posttraumatic epilepsy and therefore long-term anticonvulsant prophylaxis is not recommended. Glucocorticoid administration early after head injury also has not been found to reduce the risk of posttraumatic epilepsy. At the basic research level, there have been advances in the understanding of pathophysiological changes in posttraumatic excitatory and inhibitory synapses, and the critical period for epileptogenesis after head injury has been better defined. Finally, the development of a novel animal model, which mimicks more closely human posttraumatic epilepsy, may facilitate efforts to characterize relevant epileptogenic mechanisms and to identify clinically effective antiepileptogenic treatments. Summary: Despite the continuing lack of clinically effective agents for posttraumatic epilepsy prophylaxis, recent advances in basic and clinical research offer new hope for success in the development of new strategies for prevention and treatment.",
keywords = "Antiepileptic drugs, Epileptogenesis, Head trauma, Microdialysis, Partial seizures, Posttraumatic epilepsy",
author = "Raimondo D'Ambrosio and Emilio Perucca",
year = "2004",
month = "12",
doi = "10.1097/00019052-200412000-00014",
language = "English",
volume = "17",
pages = "731--735",
journal = "Current Opinion in Neurology",
issn = "1350-7540",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Epilepsy after head injury

AU - D'Ambrosio, Raimondo

AU - Perucca, Emilio

PY - 2004/12

Y1 - 2004/12

N2 - Purpose of review: The purpose of this short review is to provide an update on the epidemiology of posttraumatic epilepsy, associated risk factors, data from prevention studies, and recent breakthroughs in experimental research. Recent findings: There is increasing evidence that neuroimaging findings, stratification by neurosurgical procedures performed, and genomic information (e.g. apolipoprotein E and haptoglobin genotypes) may provide useful predictors of the individual risk of developing posttraumatic epilepsy. While antiepileptic drug prophylaxis can be effective in protecting against acute (provoked) seizures occurring within 7 days after injury, no antiepileptic drug treatment has been found to protect against the development of posttraumatic epilepsy and therefore long-term anticonvulsant prophylaxis is not recommended. Glucocorticoid administration early after head injury also has not been found to reduce the risk of posttraumatic epilepsy. At the basic research level, there have been advances in the understanding of pathophysiological changes in posttraumatic excitatory and inhibitory synapses, and the critical period for epileptogenesis after head injury has been better defined. Finally, the development of a novel animal model, which mimicks more closely human posttraumatic epilepsy, may facilitate efforts to characterize relevant epileptogenic mechanisms and to identify clinically effective antiepileptogenic treatments. Summary: Despite the continuing lack of clinically effective agents for posttraumatic epilepsy prophylaxis, recent advances in basic and clinical research offer new hope for success in the development of new strategies for prevention and treatment.

AB - Purpose of review: The purpose of this short review is to provide an update on the epidemiology of posttraumatic epilepsy, associated risk factors, data from prevention studies, and recent breakthroughs in experimental research. Recent findings: There is increasing evidence that neuroimaging findings, stratification by neurosurgical procedures performed, and genomic information (e.g. apolipoprotein E and haptoglobin genotypes) may provide useful predictors of the individual risk of developing posttraumatic epilepsy. While antiepileptic drug prophylaxis can be effective in protecting against acute (provoked) seizures occurring within 7 days after injury, no antiepileptic drug treatment has been found to protect against the development of posttraumatic epilepsy and therefore long-term anticonvulsant prophylaxis is not recommended. Glucocorticoid administration early after head injury also has not been found to reduce the risk of posttraumatic epilepsy. At the basic research level, there have been advances in the understanding of pathophysiological changes in posttraumatic excitatory and inhibitory synapses, and the critical period for epileptogenesis after head injury has been better defined. Finally, the development of a novel animal model, which mimicks more closely human posttraumatic epilepsy, may facilitate efforts to characterize relevant epileptogenic mechanisms and to identify clinically effective antiepileptogenic treatments. Summary: Despite the continuing lack of clinically effective agents for posttraumatic epilepsy prophylaxis, recent advances in basic and clinical research offer new hope for success in the development of new strategies for prevention and treatment.

KW - Antiepileptic drugs

KW - Epileptogenesis

KW - Head trauma

KW - Microdialysis

KW - Partial seizures

KW - Posttraumatic epilepsy

UR - http://www.scopus.com/inward/record.url?scp=10044223475&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10044223475&partnerID=8YFLogxK

U2 - 10.1097/00019052-200412000-00014

DO - 10.1097/00019052-200412000-00014

M3 - Article

C2 - 15542983

AN - SCOPUS:10044223475

VL - 17

SP - 731

EP - 735

JO - Current Opinion in Neurology

JF - Current Opinion in Neurology

SN - 1350-7540

IS - 6

ER -